Latest Insider Transactions at Bausch & Lomb Corp (BLCO)
This section provides a real-time view of insider transactions for Bausch & Lomb Corp (BLCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch & Lomb Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch & Lomb Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,134
+2.27%
|
$21,546
$19.29 P/Share
|
|
Sep 30
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,328
+2.95%
|
$25,232
$19.29 P/Share
|
|
Aug 05
2024
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
32,250
+4.89%
|
-
|
|
Aug 05
2024
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
32,250
+5.14%
|
$483,750
$15.66 P/Share
|
|
Aug 02
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+25.75%
|
-
|
|
Aug 02
2024
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.84%
|
-
|
|
Aug 02
2024
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.84%
|
-
|
|
Aug 02
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+23.54%
|
-
|
|
Aug 02
2024
|
Karen Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+45.88%
|
-
|
|
Aug 02
2024
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+22.96%
|
-
|
|
Aug 02
2024
|
Gaoxiang Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.48%
|
-
|
|
Aug 02
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.48%
|
-
|
|
Aug 02
2024
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+30.58%
|
-
|
|
Jul 25
2024
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,144
-3.75%
|
$32,160
$15.53 P/Share
|
|
Jul 25
2024
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-2.3%
|
$19,695
$15.53 P/Share
|
|
Jul 25
2024
|
Sam Eldessouky EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,113
-2.1%
|
$76,695
$15.53 P/Share
|
|
Jul 25
2024
|
Yehia Hashad EVP of R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,841
-2.78%
|
$42,615
$15.53 P/Share
|
|
Jun 28
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,764
+5.99%
|
$24,696
$14.52 P/Share
|
|
Jun 28
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,506
+4.36%
|
$21,084
$14.52 P/Share
|
|
Jun 14
2024
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-1.65%
|
$14,370
$15.09 P/Share
|
|
Apr 24
2024
|
A Robert D Bailey EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,838
-6.39%
|
$137,732
$14.9 P/Share
|
|
Apr 24
2024
|
Andrew J. Stewart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,943
-7.9%
|
$55,202
$14.9 P/Share
|
|
Mar 29
2024
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,553
+4.5%
|
$26,401
$17.3 P/Share
|
|
Mar 29
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,264
+3.85%
|
$21,488
$17.3 P/Share
|
|
Mar 29
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,481
+5.41%
|
$25,177
$17.3 P/Share
|
|
Mar 05
2024
|
Karen Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,642
+50.0%
|
-
|
|
Mar 01
2024
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
995
-1.71%
|
$15,920
$16.47 P/Share
|
|
Mar 01
2024
|
Yehia Hashad EVP of R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,143
-2.05%
|
$34,288
$16.47 P/Share
|
|
Mar 01
2024
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,098
-1.85%
|
$17,568
$16.47 P/Share
|
|
Mar 01
2024
|
Sam Eldessouky EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,854
-1.95%
|
$77,664
$16.47 P/Share
|
|
Feb 28
2024
|
Frederick Munsch SVP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
18,183
+23.83%
|
-
|
|
Feb 28
2024
|
Luc Bonnefoy President,Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
16,778
+22.06%
|
-
|
|
Feb 28
2024
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
20,973
+16.73%
|
-
|
|
Feb 28
2024
|
Andrew J. Stewart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,778
+25.15%
|
-
|
|
Feb 28
2024
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
187,919
+25.03%
|
-
|
|
Feb 28
2024
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,335
+16.84%
|
-
|
|
Feb 28
2024
|
A Robert D Bailey EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,557
+17.89%
|
-
|
|
Dec 29
2023
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+4.06%
|
$24,905
$17.06 P/Share
|
|
Dec 29
2023
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,575
+4.78%
|
$26,775
$17.06 P/Share
|
|
Dec 29
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,282
+4.06%
|
$21,794
$17.06 P/Share
|
|
Dec 29
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,502
+5.79%
|
$25,534
$17.06 P/Share
|
|
Sep 29
2023
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,474
+4.26%
|
$23,584
$16.95 P/Share
|
|
Sep 29
2023
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,585
+5.05%
|
$25,360
$16.95 P/Share
|
|
Sep 29
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+4.26%
|
$20,640
$16.95 P/Share
|
|
Sep 29
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+6.18%
|
$24,176
$16.95 P/Share
|
|
Jul 25
2023
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,240
-5.01%
|
$42,560
$19.82 P/Share
|
|
Jul 25
2023
|
Yehia Hashad EVP of R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,996
-4.57%
|
$75,924
$19.82 P/Share
|
|
Jul 25
2023
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-3.18%
|
$24,947
$19.82 P/Share
|
|
Jul 25
2023
|
Sam Eldessouky EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,218
-2.08%
|
$80,142
$19.82 P/Share
|
|
Jun 30
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,089
+3.78%
|
$21,780
$20.07 P/Share
|